Abnormal Female Puberty pp 87-107 | Cite as
Endocrine Disorders and Delayed Puberty
Abstract
Abnormal puberty is a common presenting complaint for pediatric endocrinology and gynecology practices. In girls, normal puberty may begin as early as 8 years. Though most Caucasian females develop breast tissue after the age of 8 years, race plays a role in pubertal timing, as it is more common for African American and Mexican-American females to begin puberty at an earlier age. Activation of the hypothalamic pituitary ovarian axis marks the beginning of puberty. Puberty is initiated in the hypothalamus by an increase in GnRH pulsatility and the subsequent development of the neuroendocrine system allows for changes in gonadal hormone stimulatory and inhibitory effects. Gonadotropins secreted by the pituitary in response to GnRH rise gradually. In early puberty, LH increases at night during sleep but it loses its diurnal pattern near menarche. These hormonal changes of the hypothalamus and pituitary influence the ovary, allowing estrogen levels to gradually rise to adult ranges. Rising estrogen levels account for the development of secondary sexual characteristics and ultimately stimulate endometrial growth allowing for menarche to occur.
Keywords
Puberty Pubertal delay Tanner staging Menarche Primary amenorrhea Gonadotropins Estradiol Hypergonadotropic hypogonadism Primary ovarian failure Primary ovarian insufficiency Hypothyroidism Hashimoto’s thyroiditis Hypogonadotropic hypogonadism HyperprolactinemiaAbbreviations
- ACTH
Adrenocorticotropic hormone
- ART
Assisted reproductive technology
- BMI
Body mass index
- CBC
Complete blood count
- CMP
Comprehensive Metabolic Panel
- DHEAS
Dehydroepiandrosterone sulfate
- FSH
Follicle stimulating hormone
- GnRH
Gonadotropin-releasing hormone
- HCG
Human chorionic gonadotropin
- IVF
In vitro fertilization
- LH
Luteinizing hormone
- MRI
Magnetic resonance imaging
- OCP
Oral contraceptive pill
- POF
Primary ovarian failure
- POI
Primary ovarian insufficiency
- PRL
Prolactin
- TBG
Thyroid-binding globulin
- TSH
Thyroid stimulating hormone
- T4
Thyroxine
- TS
Turner syndrome
References
- 1.Nakamoto JM. Myths and variations in normal pubertal development. Western J Med. 2000;172:182–5.CrossRefGoogle Scholar
- 2.Bordini B, Rosenfield R. Normal pubertal development: Part I: the endocrine basis of puberty. Pediatr Rev. 2011;32:223–9.CrossRefPubMedGoogle Scholar
- 3.Stang J, Story M. Understanding adolescent eating behaviors. In: Stang J, Story M, editors. Guidelines for adolescent nutrition services. Minneapolis, MN: University of Minnesota School of Public Health; 2005. p. 1–8.Google Scholar
- 4.Bordini B, Rosenfield R. Normal pubertal development: Part II: clinical aspects of puberty. Pediatr Rev. 2011;37:281–91.CrossRefGoogle Scholar
- 5.Rosenfield R, Cooke D, Radovick S. The ovary and female maturation. In: Sperling M, editor. Pediatric endocrinology. 3rd ed. Pittsburgh: Saunders; 2008. p. 564–78.Google Scholar
- 6.Dwyer A, Phan-Hug F, Hauschild M, Elowe-Gruau E, Pitteloud N. Hypogonadism in adolescence. Eur J Endocrinol. 2015;173(1):R15–24.CrossRefPubMedGoogle Scholar
- 7.Medicine TPCotASfR. Current evaluation of amenorrhea. Fertil Steril. 2008;90:S219–S25.Google Scholar
- 8.Garel L, Dubois J, Grignon A, Filiatrault D, Vliet GV. US of the pediatric female pelvis: a clinical perspective. Radiographics. 2001;21:1393–407.CrossRefPubMedGoogle Scholar
- 9.Pavlik EJ, DePriest PD, Gallion HH, et al. Ovarian volume related to age. Gynecol Oncol. 2000;77:410–2.CrossRefPubMedGoogle Scholar
- 10.Nelson L. Primary ovarian insufficiency. New Engl J Med. 2009;360:606–14.CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Menopause. American Congress of Obstetricians and Gynecologists, 2013. Accessed February 26, 2015, at http://www.acog.org/Patients/FAQs/Menopause.
- 12.American Congress of Obstetricians and Gynecologists. Primary ovarian insufficiency in adolescents and young women. 2014. Accessed February 26, 2015, at http://www.acog.org/%20Resources-And-Publications/Committee-Opinions/Committee-on-Adolescent-Health-Care/Primary-Ovarian-Insufficiency-in-Adolescents-and-Young-Women.
- 13.Carr BR. Disorders of the ovaries and female reproductive tract. In: Wilson JD et al., editors. William’s textbook of endocrinology. 9th ed. Philadelphia: W.B. Saunders; 1998. p. 485.Google Scholar
- 14.Rafique S, Sterling E, Nelson L. A new approach to primary ovarian insufficiency. Obstet Gynecol Clin North Am. 2012;39:567–86.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Groff A, Covington S, Halverson L, et al. Assessing the emotional needs of women with spontaneous premature ovarian failure. Fertil Steril. 2005;83:1734–41.CrossRefPubMedGoogle Scholar
- 16.Gravholt C. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol. 2004;151:657–87.CrossRefPubMedGoogle Scholar
- 17.Simon J. What's new in hormone replacement therapy: Focus on transdermal estradiol and micronized progesterone. Climacteric. 2012;15:3–10.CrossRefPubMedGoogle Scholar
- 18.Lignières B. Oral micronized progesterone. Clin Ther. 1999;21:41–60.CrossRefPubMedGoogle Scholar
- 19.Sherif K. Benefits and risks of oral contraceptives. Am J Obstet Gynecol. 1999;180:S343–S8.CrossRefPubMedGoogle Scholar
- 20.Fehr AD, Mounsey A, Yates JE, Flake D. Cardiovascular risks of combined oral contraceptive use. Am Fam Physician. 2012;86:1–2.PubMedGoogle Scholar
- 21.Pediatrics AAo. Bone densitometry in children and adolescents. Pediatrics. 2011;127:189–94.CrossRefGoogle Scholar
- 22.Etherington J, Harris PA, Nandra D, et al. The effect of weight-bearing exercise on bone mineral density: a study of female ex-elite athletes and the general population. J Bone Miner Res. 1996;11:1333–8.CrossRefPubMedGoogle Scholar
- 23.Eunice Kennedy Shriver National Institute of Child Health and Human Development. What are the treatments for POI? 2013. Accessed February 26, 2015, at https://www.nichd.nih.gov/health/topics/poi/conditioninfo/Pages/treatments.aspx.
- 24.Shelling AN. Premature ovarian failure. Reproduction. 2010;140:633–41.CrossRefPubMedGoogle Scholar
- 25.Bidet M, Bachelot A, Touraine P. Premature ovarian failure: predictability of intermittent function and response to ovulation induction agents. Curr Opin Obstet Gynecol. 2008;20:416–20.CrossRefPubMedGoogle Scholar
- 26.Khandelwal D, Tandon N. Overt and subclinical hypothyroidism: who to treat and how. Drugs. 2012;72:17–33.CrossRefPubMedGoogle Scholar
- 27.Almandoz J, Gharib H. Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am. 2012;96:203–21.CrossRefPubMedGoogle Scholar
- 28.National Institute of Diabetes and Digestive and Kidney Disorders. Hypothyroidism. 2013. Accessed February 26, 2015, at http://www.niddk.nih.gov/health-information/health-topics/endocrine/hypothyroidism/Pages/fact-sheet.aspx.
- 29.Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001;81:1097–142.PubMedGoogle Scholar
- 30.Weber G, Vigone M, Chiumello G. Thyroid function and puberty. J Pediatr Endocrinol Metab. 2003;16:S253–7.Google Scholar
- 31.Koutras D. Disturbances of menstruation in thyroid disease. Ann N Y Acad Sci. 1997;816:280–4.CrossRefPubMedGoogle Scholar
- 32.Indumathi C, Bantwal G, Patil M. Primary hypothyroidism with precocious puberty and bilateral cystic ovaries. Indian J Pediatr. 2007;74:781–3.CrossRefPubMedGoogle Scholar
- 33.Dijkstra G, de Rooij DG, de Jong FH, van den Hurk R. Effect of hypothyroidism on ovarian follicular development, granulosa cell proliferation and peripheral hormone levels in the prepubertal rat. Eur J Endocrinol. 1996;134:649–54.CrossRefPubMedGoogle Scholar
- 34.Krassas GE. Thyroid disease and female reproduction. Fertil Steril. 2000;74:1063–70.CrossRefPubMedGoogle Scholar
- 35.Kakuno Y, Amino N, Kanoh M, Kawai M, Fujiwara M. Menstrual disturbances in various thyroid diseases. Endocr J. 2010;57:1017–22.CrossRefPubMedGoogle Scholar
- 36.Krassas G, Pontikides N, Kaltsas T, et al. Disturbances of menstruation in hypothyroidism. Clin Endocrinol (Oxf). 1999;50:655–9.CrossRefGoogle Scholar
- 37.Livingstone M, Fraser IS. Mechanisms of abnormal uterine bleeding. Hum Reprod Update. 2002;8:60–7.CrossRefPubMedGoogle Scholar
- 38.Kaplowitz P. Subclinical hypothyroidism in children: normal variation or sign of a failing thyroid gland? Int J Pediatr Endocrinol. 2010;2010:281453.CrossRefPubMedPubMedCentralGoogle Scholar
- 39.Medicine PCotASfR. Current evaluation of amenorrhea. Fertil Steril. 2006;86:S148.Google Scholar
- 40.Viswanathan V, Eugster E. Etiology and treatment of hypogonadism in adolescents. Pediatr Clin North Am. 2011;58:1181–200.CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Samuels MH, Ridgway EC. Central hypothyroidism. Endocrinol Metab Clin North Am. 1992;21:903–19.PubMedGoogle Scholar
- 42.Prabhakar V, Shalet S. Aetiology, diagnosis, and management of hypopituitarism in adult life. Postgrad Med J. 2006;82:259–66.CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Grossman AB. The diagnosis and management of central hypoadrenalism. J Clin Endocrinol Metabol. 2010;95:4855–63.CrossRefGoogle Scholar
- 44.Mullur R, Liu Y-Y, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94:355–82.CrossRefPubMedPubMedCentralGoogle Scholar
- 45.Ross J, Czernichow P, Biller BMK, Colao A, Reiter E, Kiess W. Growth hormone: health considerations beyond height gain. Pediatrics. 2010;125:e906–18.CrossRefPubMedGoogle Scholar
- 46.Emons J, Chagin AS, Sävendahl L, Karperien M, Wit JM. Mechanisms of growth plate maturation and epiphyseal fusion. Horm Res Paediatr. 2011;75:383–91.CrossRefPubMedGoogle Scholar
- 47.DiVasta A, Gordon C. Hormone replacement therapy and the adolescent. Curr Opin Obstet Gynecol. 2010;22:363–8.CrossRefPubMedGoogle Scholar
- 48.Mancini T, Casanueva FF, Giustina A. Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am. 2008;37:67–99.CrossRefPubMedGoogle Scholar
- 49.Herman V et al. Clonal origin of pituitary adenomas. J Clin Endocrinol Metabol. 1990;71:1427–33.CrossRefGoogle Scholar
- 50.Saranac L, Zivanovic S, Radovanovic Z, Kostic G, Markovic I. Hyperprolactinemia: different clinical expression in childhood. Horm Res Paediatr. 2010;73:187–92.CrossRefPubMedGoogle Scholar
- 51.Halac I, Zimmerman D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst. 2005;21:640–8.CrossRefPubMedGoogle Scholar
- 52.Molitch ME. Drugs and prolactin. Pituitary. 2008;11:209–18.CrossRefPubMedGoogle Scholar
- 53.Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. J Clin Invest. 1973;52:2324–9.CrossRefPubMedPubMedCentralGoogle Scholar
- 54.Wang AT et al. Treatment of hyperprolactinemia: a systemic review and meta-analysis. Syst Rev. 2012;1:33.CrossRefPubMedPubMedCentralGoogle Scholar
- 55.Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med. 1994;331:904–9.CrossRefPubMedGoogle Scholar
- 56.Shibli-Rahhal A, Schlecte J. Hyperprolactinemia and infertility. Endocrinol Metab Clin North Am. 2011;40:837–46.CrossRefPubMedGoogle Scholar
- 57.Melmed S, Kleinberg D. Pituitary masses and tumors. In: Melmed S, Polonsky K, Larsen R, Kronenberg H, editors. Williams textbook of endocrinology. 12th ed. Philadelphia: Elsevier Saunders; 2011. p. 229–90.CrossRefGoogle Scholar